In 2026, ООО «АЛМЕА» (ALMEA LLC) received Skolkovo project participant status, registry entry No. 112898, on the basis of in-house technology and a 2024 patent on a biocomplex.
The status opens Skolkovo’s infrastructure to the company and confirms the research course of the laboratory in Saint Petersburg.
For partners it is the same principle the laboratory works by: a formula has a source, and only then a promise on the pack.